| Travere Therapeutics Inc (TVTX) | |||
|---|---|---|---|
| 28.63 0.8 (2.87%) | 08-08 16:00 | ||
| Open: | 27.67 | Pre. Close: | 27.83 |
| High: | 29.14 | Low: | 27.22 |
| Volume: | 1,457,816 | Market Cap: | 1,831M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 29.157 - 29.244 | 29.244 - 29.34 |
| Low: | 26.969 - 27.07 | 27.07 - 27.183 |
| Close: | 28.445 - 28.603 | 28.603 - 28.781 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 34.04  One year: 39.75 |
| Support: | Support1: 24.73 Support2: 22.00 |
| Resistance: | Resistance1: 29.14 Resistance2: 34.04 |
| Pivot: | 24.48 |
| Moving Averages: | MA(5): 25.85 MA(20): 24.48 MA(100): 24.99 MA(250): 25.87 |
| MACD: | MACD(12,26): 0.55 Signal(12,26,9): 0.06 |
| %K %D: | %K(14,3): 90.19 %D(3): 72.06 |
| RSI: | RSI(14): 70.30 |
| 52-Week: | High: 31.65 Low: 13.7519 Change(%): 60.7 |
| Average Vol(K): | 3-Month: 819 10-Days: 1065 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TVTX ] has closed It is unclear right now based on current values. 50.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 63.51 |
| Shares Float (M) | 46.22 |
| % Held by Insiders | 1.44 |
| % Held by Institutions | 112.98 |
| Shares Short (K) | 6690 |
| Shares Short Prior Month (K) | 6630 |
| Stock Financials | |
|---|---|
| EPS | -3.290 |
| Book Value (p.s.) | 3.280 |
| Profit Margin | -88.46 |
| Operating Margin | -68.95 |
| Return on Assets (ttm) | -12.4 |
| Return on Equity (ttm) | -70.8 |
| Qtrly Rev. Growth | 2.3 |
| Gross Profit (p.s.) | 3.475 |
| Sales Per Share | 3.599 |
| EBITDA (p.s.) | -2.046 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -43.64 |
| Levered Free Cash Flow (M) | -13.74 |
| Stock Valuation | |
|---|---|
| PE Ratio | -8.70 |
| PEG Ratio | -0.02 |
| Price to Book value | 8.73 |
| Price to Sales | 7.95 |
| Price to Cash Flow | -41.67 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
